经皮冠脉介入治疗老年冠心病心绞痛的临床效果

Clinical effect of percutaneous coronary intervention in the treatment of angina pectoris in elderly patients with coronary heart disease

目的探讨经皮冠脉介入(PCI)治疗老年冠心病心绞痛的临床效果。方法选取2016年1月~2018年12月海门市人民医院收治的80例老年冠心病心绞痛患者为研究对象,按照随机数字表法及自愿原则分为保守治疗组(40例)和PCI组(40例),保守治疗组采取常规药物治疗,PCI组采取PCI治疗,随访12个月,比较观察两组患者的治疗总有效率,西雅图心绞痛调查量表(SAQ)评分、心脏不良事件(再发心绞痛、心肌梗死、心源性死亡)发生率。结果PCI组治疗总有效率97.50%,高于保守治疗组的85.00%,差异有统计学意义(P<0.05)。PCI组SAQ各项评分(心绞痛发作、心绞痛稳定状态、躯体活动受限、主观感受以及治疗方案满意度)均高于保守治疗组,差异有统计学意义(P<0.05)。两组心脏不良事件发生率比较,差异无统计学意义(P>0.05)。结论PCI治疗老年冠心病心绞痛的临床疗效显著,能够提高老年冠心病心绞痛患者的生活质量,值得临床推广应用。

Objective To explore the clinical effect of percutaneous coronary intervention(PCI)in the elderly patients with coronary heart disease and angina pectoris.Methods A total of 80 elderly patients with coronary heart disease and angina pectoris admitted to Haimen People′s Hospital from January 2016 to December 2018 were selected as the research objects,they were divided into the conservative treatment group(40 cases)and the PCI group(40 cases)according to the random number table method and voluntary principles.The conservative treatment group received conventional drug therapy,and the PCI group received PCI treatment,followed up for 12 months.The total effectiveness of treatment,Seattle angina questionnaire(SAQ)score,cardiac adverse events(recurrent angina pectoris,myocardial infarction,cardiogenic death)were compared between the two groups.Results The total effective rate of PCI group was 97.50%,higher than that of conservative group(85.00%),the difference was statistically significant(P<0.05).The SAQ scores of PCI group(angina attack,angina stable state,limited physical activity,subjective feeling and treatment plan satisfaction)were all higher than those of the conservative group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of cardiac adverse events between the two groups(P>0.05).Conclusion PCI has a significant clinical effect on angina pectoris in elderly patients with coronary heart disease,which can improve the quality of life of elderly patients with coronary heart disease and angina pectoris,and is worthy of clinical application.